Predictors of clinical response of non-small cell cancer to gefitinib

JAMA. 2004 Apr 7;291(13):1563; author reply 1563-4. doi: 10.1001/jama.291.13.1563-a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Enzyme Inhibitors / therapeutic use*
  • ErbB Receptors / antagonists & inhibitors*
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Quinazolines
  • ErbB Receptors
  • Gefitinib